828 agencies indexed·Latest entry: 4 June 2026
Home/Industries/Healthcare
Industry · 198 agencies

Healthcare agencies.

Healthcare marketing is the discipline of promoting medicines, medical devices, private healthcare services and patient-facing health information under UK rules that ban direct-to-consumer advertising of prescription medicines, gate every clinical claim behind documented evidence, and route pharma promotion through the PMCPA-administered ABPI Code of Practice.

At a glance
  • 198 UK agencies with healthcare experience
  • Across 29 UK locations
  • Reviewed 18 May 2026
Showing 193-198 of 198 healthcare agenciesView in full archive
Mobikasa logo
Mobikasa
Independent·London·51-200 Employees

As a powerhouse of digital strategy, Mobikasa is composed of an assorted mix of strategists, creators, developers, scribes, directors, and producers, united by a cutting-edge philosophy. This multifaceted team collaboratively engineers pioneering digital solutions that resonate with global audiences. With an industry tenure exceeding a decade, Mobikasa's designs, underpinned by scientific insight,

Galexia Creative Agency logo
Galexia Creative Agency
Independent·London·2-10 Employees

Galexia Creative Agency, a creative hub, specialises in fostering the growth of start-ups. Our services span from customised WordPress website development to managing social media and optimising for SEO, all under the umbrella of superior project management. This not only eases the burden of running a start-up but also ensures its growth. At Galexia, our distinctive method concentrates on nurturin

The One Stop Marketing logo
The One Stop Marketing
Independent·London·2-10 Employees

The One Stop Marketing Ltd, a premier digital marketing agency situated in London, UK, is renowned for its distinct focus on augmenting brands' online footprint. Leveraging data-driven approaches, they enhance visibility and elevate market value. Providing a diverse array of digital marketing solutions, The One Stop Marketing Ltd guarantees personalised strategies that effectively amplify business

Frost Creative logo
Frost Creative
Independent·Southampton·11-50 Employees

Searching for a result-oriented branding + creative consultancy? We are an award-winning, no-nonsense strategic and creative consultancy transforming what makes you unique into rocket fuel for growth. Our expertise crosses strategy, design, digital, print and the physical environment. Everywhere your audience goes and everywhere you need to be.

Pimento logo
Pimento
Independent·London·1000+ Employees

Pimento, a leading full-service UK-based agency, is celebrated for its extensive network of independent digital, marketing agencies, businesses, and consultants. Pimento's unique strength lies in its capacity to craft tailor-made teams that meticulously match the specific briefs of clients, utilising a wide talent base to fulfil diverse marketing, business, and technology requirements. Providing a

Lambda Films London logo
Lambda Films London
Specialist·London·2-10 Employees

Lambda Films, a comprehensive video production and animation firm headquartered in London, also boasts branches in Cambridge, Norwich, and Essex. What differentiates Lambda Films is their unwavering dedication to superior production quality, a unique cinematic flair, and an innovative methodology that covers television advertisements, promotional videos, documentaries, and business-related content

Page 9 of 9
Editor's note
AgencyIndex lists 196 UK agencies positioning into healthcare. They split roughly six ways: ABPI-Code shops working ethical pharma for HCP audiences, consumer-health agencies behind OTC and self-care brands governed by the CAP Code and PAGB, medical-device specialists handling UKCA and CE-route launches, private-practice marketing for clinics, dental groups and cosmetic providers, NHS engagement teams running public-health and recruitment programmes, and medtech B2B agencies serving diagnostics, digital-health and life-sciences companies. The sector is distinct because prescription medicines cannot be advertised to the public at all. Part 14 of the Human Medicines Regulations 2012 prohibits it, the MHRA enforces it, and the PMCPA polices the ABPI Code of Practice that governs every interaction a pharmaceutical company has with healthcare professionals, patients and patient organisations. Medical devices sit under MHRA oversight with claims tied tightly to the certified intended purpose, CE marks accepted in Great Britain until 30 June 2028 for general devices and 30 June 2030 for IVDs, and a separate EU regime for Northern Ireland. Private healthcare marketing is policed by the ASA under CAP Code Section 12, with the GMC and GDC adding professional-standards constraints on individual clinicians: no unjustifiable claims, no guaranteed outcomes, no exploiting patient vulnerability. What is shifting in 2026 is the enforcement texture, not the underlying rules. The ASA has moved to a more proactive AI-assisted monitoring model and has been visibly active on weight-loss-medicine advertising, ruling against indirect references and partial pen imagery that point to prescription-only GLP-1 products. The MHRA's 2025 to 2026 reform programme is tightening post-market surveillance and the substantiation expected behind device claims. Pharma is rebuilding its HCP engagement model post-pandemic around hybrid field-and-digital touchpoints and approval-workflow platforms like Veeva PromoMats, and AI-generated content is forcing tighter medical-review gates because the regulator does not care whether a misleading claim came from a human or a model.
Common briefs
HCP campaigns for ethical pharmaceutical brands under the ABPI CodePatient-education and disease-awareness content within PMCPA limitsMedical-device launches under UKCA and transitional CE recognitionPrivate-practice acquisition for clinics, dental groups and cosmetic providersNHS engagement, public-health and workforce-recruitment programmesOTC and consumer-health campaigns under CAP Code Section 12Medtech and diagnostics B2B demand generationPatient-organisation relationships and shared-decision content
Regulatory landscape
MHRA · PMCPA · ABPI · ASA · GMC · GDC
no DTC for Rx, claims tied to certified intended purpose

Pharmaceutical promotion is governed by Part 14 of the Human Medicines Regulations 2012, which prohibits advertising prescription-only medicines to the public; the MHRA enforces the statutory regime and the PMCPA administers the ABPI Code of Practice on behalf of the industry, with the Code requiring every promotional item to be certified by a final signatory before use and providing sanctions including public reporting of breaches. Medical devices are regulated under the UK Medical Devices Regulations 2002 as amended: claims must match the device's certified intended purpose and supporting evidence, Great Britain accepts UKCA or transitional CE marking (general devices to 30 June 2028, IVDs to 30 June 2030), and Northern Ireland follows the EU CE framework. ASA decisions under CAP Code Section 12 cover medicines, devices, health-related products and beauty claims, with 2024 and 2025 rulings repeatedly hitting clinic ads that imply prescription-only weight-loss treatments. The GMC and GDC set parallel professional-standards rules for doctors and dentists: marketing must be accurate, verifiable, not misleading, not exploitative of vulnerability, and not create unjustified expectations about outcomes. The ICO enforces UK GDPR and PECR over patient data and electronic marketing on top of everything else.

Specialist signals
5 signals
of real healthcare-sector experience
  • · ABPI-Code-trained copywriters, designers and account leads, with a documented medical-and-regulatory review workflow that maps onto a final-signatory sign-off before any promotional item goes live
  • · PMCPA and MHRA submission experience for promotional materials and advertising complaints, plus comfort with the device-claims rules tying every benefit statement back to the certified intended purpose
  • · Named UK case studies across at least one of ethical pharma, OTC, medical devices and private healthcare, with evidence of working under approval-workflow platforms such as Veeva PromoMats, iCapture or Aprimo
  • · Fluency in the HCP-versus-patient audience split, with separate creative, channel and gating logic for prescriber-only content versus consumer-facing OTC or service marketing
  • · Demonstrated medical-affairs liaison capability, meaning the agency can sit in a room with medical, regulatory and legal reviewers and defend every claim, reference and image with a documented evidence trail
Sector watch-outs
5 to watch
in any healthcare pitch
  • · Creative concepts that will not clear medical and regulatory review, with hero claims that imply efficacy beyond the licensed indication or device intended purpose and no evidence of how the agency expects to substantiate them
  • · No working knowledge of the ABPI Code or the PMCPA process for Rx work, with proposals that treat pharma like any other regulated category and miss the certification and final-signatory steps entirely
  • · Private-healthcare creative that reads like consumer retail: superlatives, guaranteed outcomes, before-and-after imagery without context, and discount-led pressure tactics that fail GMC, GDC and ASA tests
  • · Weak referencing and evidence trail behind clinical or performance claims, with no audit log linking each claim to a source and no view on how that holds up if the MHRA, PMCPA or ASA writes asking for substantiation
  • · No grasp of the HCP-versus-patient gating model, with the same creative being pitched at prescribers and the public and no plan for sign-in walls, professional-verification gates or separate content paths
Frequently asked

What brands ask about agencies for healthcare.

5 questions our editors get most often, answered honestly. No agency-marketing speak.

Curated by humans

Fees vary sharply by sub-sector because the compliance load is so different. Private-practice and dental marketing typically runs £2,000-8,000 a month for a focused programme covering paid search, local SEO and content under GMC, GDC and ASA rules. OTC and consumer-health work clusters at £8,000-30,000 a month for integrated campaigns with brand, paid, social and CAP Code review. Ethical pharma is the most expensive layer, with HCP programmes routinely sitting at £20,000-80,000 a month once medical-and-regulatory review, ABPI Code certification workflow, and Veeva PromoMats production are factored in. Medical-device launches usually scope as projects in the £30,000-300,000 range depending on whether the agency is also running UKCA-route claims-substantiation work. Media spend sits outside agency fees and dominates the consumer-health budget.